Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors (Business Wire via Yahoo! Finance)

PASADENA, Calif.—-Arrowhead Research Corporation today announced that its majority owned subsidiary, Calando Pharmaceuticals, Inc., has appointed Mostafa Analoui, Ph.D., and Bruce D.
(read on…)

Related items

• Arrowhead Appoints Chief Financial Officer (Business Wire via Yahoo! Finance)
• Arrowhead Research to Report Fiscal 2009 Fourth Quarter and Year-End Financial Results and Host Conference Call on … (Business Wire via Yahoo! Finance)
• Arrowhead Reports Fiscal 2010 First Quarter Financial Results (Business Wire via Yahoo! Finance)
• Arrowhead Receives Additional 180-Day Grace Period to Comply with the NASDAQ $1.00 Minimum Bid Requirement (Business Wire via Yahoo! Finance)
• Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio to Luna Innovations (Business Wire via Yahoo! Finance)

Tags: Arrowhead, arrowhead research, Bruce, Calif., Corporation, nano, nanotech, PASADENA, pharmaceuticals inc, Research, subsidiary, today, today announced that

This entry was posted on Wednesday, November 4th, 2009 at 4:51 pm and is filed under Services.